Last update 20 Mar 2025

Zucapsaicin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(Z)-Capsaicin, Civamide, Civanex
+ [6]
Target
Action
agonists
Mechanism
TRPV1 agonists(Vanilloid receptor agonists)
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Canada (15 Jul 2010),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC18H27NO3
InChIKeyYKPUWZUDDOIDPM-VURMDHGXSA-N
CAS Registry25775-90-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Osteoarthritis
Canada
-15 Jul 2010
Pain
Canada
-15 Jul 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Trigeminal NeuralgiaPhase 1
United States
01 Mar 2014
Neuralgia, PostherpeticPhase 1
United States
01 Mar 2009
Neuralgia, PostherpeticPhase 1
Canada
01 Mar 2009
Dry Eye SyndromesDiscovery
United States
01 May 2014
Neuralgia, PostherpeticDiscovery
United States
01 Mar 2009
Neuralgia, PostherpeticDiscovery
Canada
01 Mar 2009
Post-traumatic neuralgiaDiscovery
Canada
01 Mar 2009
Post-traumatic neuralgiaDiscovery
United States
01 Mar 2009
Osteoarthritis, KneeDiscovery-01 Jun 2003
Cluster HeadacheDiscovery
United States
01 Jan 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
232
ziqaxnkkpm(alnlgaukdr) = ddhpybfuvj avpxsqyevm (xixxdtnqal, bagwqyvvdx - jemaapmogs)
-
01 Dec 2023
Phase 2
63
Combination pharmacotherapy - transdermal nicotine patch + nicotine gum+Bupropion Sustained Release+Nicotine replacement therapy - nicotine gum+Varenicline+Nicotine replacement therapy - transdermal nicotine patch
(Tailored Intervention Group)
gfohphvwjv(nqpdkpgouj) = lugmhqebxn oiiqbvlhqz (vqtptpeyxy, loqqgkkbis - hkvsnqhjoj)
-
19 Jul 2017
Combination pharmacotherapy - transdermal nicotine patch + nicotine gum+Bupropion Sustained Release+Nicotine replacement therapy - nicotine gum+Varenicline+Nicotine replacement therapy - transdermal nicotine patch
(Enhanced Standard of Care Group)
gfohphvwjv(nqpdkpgouj) = mlldffsqey oiiqbvlhqz (vqtptpeyxy, grtluvfged - deiufpoyma)
Phase 2
11
(Double Blind Treatment Period Civamide Nasal Spray)
zgzlniloru(rtpxiulwjp) = qgeiniybnu kjzqkmulzx (kupqifiaqh, rsyogcuzpy - fgiobxakyt)
-
01 Mar 2017
Placebo
(Double Blind Treatment Period Placebo Nasal Spray)
zgzlniloru(rtpxiulwjp) = gcykvrgszy kjzqkmulzx (kupqifiaqh, smuphizoaq - htqsoehqsv)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free